Fox Chase Cancer Center Physician Receives Pennsylvania Grant Funded by Tax-Refund Check-Off
PHILADELPHIA (April 25, 2003) — Jonathan D. Cheng, MD, of Rydal, Pa., a medical oncologist and researcher at Fox Chase Cancer Center, is among six recipients of cancer research grants funded by a voluntary check-off on state income tax forms. The grants were made possible by the support of more than 23,000 of Pennsylvanians who donated a portion of their state income-tax refunds to the Breast and Cervical Cancer Research Fund or made personal donations to the fund through the Department of Health.
The PA Department of Health awarded grants totaling $209,997 to six scientists from cancer research centers statewide. Cheng's $34,997 grant will fund research of therapeutic inhibition of fibroblast activation protein, a protein found in breast cancer that is important for tumor growth and its spread or metastasis. Cheng was the only grant recipient in the Philadelphia region.
"The research conducted through these grants allows us to learn more about the causes, prevention, early detection measures and treatments of breast and cervical cancer," Acting Secretary of Health Rob Muscalus said. "This knowledge gives us a real chance to successfully win the fight over cancer."
Cheng is board certified in medical oncology. His clinical specialties include gastrointestinal malignancies and head and neck cancer. His laboratory research interest is in tumor microenvironment.
Cheng received his undergraduate degree in computer science summa cum laude at Marquette University. He received his medical degree in 1992 at the University of Minnesota in Minneapolis, Minn., where he also completed his residency and internship. Cheng completed his clinical fellowship in medical oncology and his clinical research fellowship at Roswell Park Cancer Institute, Buffalo, New York; and his laboratory research fellow at Fox Chase Cancer Center. Cheng joined Fox Chase in 1999 as an associate member of the medical science division.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).